Davie, A., Traoré, S., Giovannitti, M., Pompilio, G., Lambton, M., Cakar, E. and Chatterjee, A. 2023. Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy. Global and Regional Health Technology Assessment. 10, 1 (Sep. 2023), 62–69. DOI:https://doi.org/10.33393/grhta.2023.2561.